 Smaller Footprint, Improved User Experience and Lower Cost to Drive Adoption REDWOOD CITY, CA ACCESSWIRE August 9, 2021 Avinger, Inc. NASDAQ:AVGR, a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease PAD, today announced the submission of a 510k application to the U.S. Food Drug Administration FDA for its new Lightbox 3 imaging console. Avingers Lightbox 3 represents an important leap forward in imaging, portability and capability, commented Jeff Soinski, Avingers President and CEO. 